Basic HIV Vaccine Discovery Research (R01)

Post Date

May 19th 2009

Application Due Date

November 9th 2009

Funding Opportunity Number

RFA-AI-09-024

CFDA Number(s)

93.855
93.856

Funding Instrument Type(s)

Grant

Funding Activity Categories

Health

Eligibility Categories

State Governments
County Governments
City or Township Governments
Special District Governments
Independent School Districts
Public and State Controlled Institutions of Higher Education
Federally Recognized Native American Tribal Governments
Public Housing Authorities or Indian Housing Authorities
Non-Federally Recognized Native American Tribal Organizations
Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Private Institutions of Higher Education
For-Profit Organizations (Except Small Businesses)
Small Businesses
Other

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Funding

• Estimated Total Funding:

  $10000000

• Award Range:

  $None - $350000

Grant Description

Purpose. The aim of this Funding Opportunity Announcement (FOA) issued by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), is to stimulate the discovery of an effective prophylactic HIV-1 vaccine by soliciting Research Project Grant (R01) applications for hypothesis-driven basic research in HIV/AIDS, and general virology and immunology focused on that aim. The emphasis is on discovery, including the identification of new concepts and approaches that will inform the design of an optimal prophylactic HIV-1 vaccine, or the implementation of applicable concepts and/or approaches that have been employed successfully in the development of vaccines for other infections. Mechanism of Support. This FOA will utilize the NIH Research Project R01 grant mechanism. This FOA will utilize the NIH Research Project R01 grant mechanism, and runs in parallel with FOAs of similar scope, including PA-06-519 Phased Innovation Awards (PIA) in AIDS Vaccine Research and PAR-06-285 HIVRAD that solicit applications under the R21/R33 and P01 mechanisms, respectively. Funds Available and Anticipated Number of Awards. NIAID intends to commit approximately $10M in total costs in FY 2010 to fund 15-25 applications submitted in response to this FOA. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  National Institutes of Health

• Agency Contact:

  NIH OER Webmaster
  FBOWebmaster@OD.NIH.GOV
  

• Agency Mailing Address:

  If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

• Agency Email Address:

  FBOWebmaster@OD.NIH.GOV

• More Information:

  http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-09-024.html